针对特定患者群体的DOAC处方
Kevin Schleich1,2, Brigit E Ray2
1Department of Pharmaceutical Care, University of Iowa, Iowa City.
The Journal of family practice
|August 7, 2023
概括
处方药物需要仔细考虑患者的并发症,如肥胖,脏疾病,癌症和血栓友. 优化药物选择和剂量对于这些复杂人群的安全和有效治疗至关重要.
科学领域:
- 临床药理学 临床药理学
- 内部医学 内部医学
- 药物治疗 药物治疗
背景情况:
- 肥胖,脏疾病,癌症和血栓形成症是普遍存在的疾病,它们显著影响药物的药理动力学和药理动力学.
- 这些并发症需要个性化的处方方法,以确保治疗疗效,并尽量减少不良事件.
- 缺乏针对这些患者群体的具体指导,可能导致治疗结果低于最佳.
研究的目的:
- 为患有肥胖,脏疾病,癌症或血栓友爱症的患者概述关键的处方考虑因素.
- 突出潜在的药物相互作用和在这些复杂的患者资料中所需的剂量调整.
- 为优化弱势群体药物治疗提供一个框架.
主要方法:
- 审查当前的文献和临床指南.
- 分析与每个并发性疾病相关的药理动力学和药理动力学变化.
- 综合基于证据的药物选择和剂量建议.
主要成果:
- 特定的药物类别需要在功能障碍时调整剂量.
- 肥胖会改变药物的分发和新陈代谢,需要根据体重调整剂量.
- 癌症患者可能会经历药物清除的改变,并增加毒性风险.
- 血栓友会影响抗凝剂的选择,需要仔细监测.
结论:
- 个性化处方对于患有肥胖,脏疾病,癌症或血栓友爱症的患者至关重要.
- 医疗保健提供者必须意识到这些并发症带来的独特挑战.
- 坚持基于证据的指导方针可以提高患者的安全性和治疗的有效性.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.9K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.9K
Coronary Artery Disease IV: Preventive Measures
24
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
24
Anticoagulant Drugs: Low-Molecular-Weight Heparins
753
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
753
Coronary Artery Disease V: Interprofessional Care
9
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10


